“alexion-pharmaceuticals” Archives

in
Entry Author Date Location
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma 10/10/19 Boston
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet 08/30/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
The Finalists for the 2019 Xconomy Awards Are … 07/10/19 Boston
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases 04/08/19 Boston
Dyne Therapeutics Emerges With $50M to Take On Rare Muscle Disease 04/03/19 Boston
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again 02/14/19 National
With Its First Human Data, Solid Slips in Duchenne Gene Therapy Race 02/07/19 Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Eyeing $500M, Moderna Outlines Plans for Biotech’s Biggest IPO Ever 11/09/18 Boston
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M 10/29/18 Boston
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
Syntimmune Turns Drug For Rare Anemia Into $400M Alexion Buyout 09/26/18 Boston
Alexion Hits Study Goals, Could Expand Blockbuster Drug to CNS 09/24/18 Boston
As Sarepta Preps Data, FDA Lifts Hold on Solid’s Duchenne Gene Therapy 06/18/18 Boston
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined 05/24/18 Boston
Moderna’s Billions: Will Building Big Before an IPO Pay Off? 05/09/18 Boston
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More 03/16/18 National
Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More 12/08/17 Boston
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life 09/25/17 New York
Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More 09/15/17 National
Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists 08/10/17 Boston
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY 08/09/17 New York
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
Page 1 of 4 next page »